Operating cash flow increased 28.1%
Operating cash flow changed +28.1% from the comparable as-filed period.
$938.9M→$1.2B2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →WEC financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy increased 94.2%
Free-cash-flow proxy changed +94.2% from the comparable as-filed period.
-$625.7M→-$36.4M0 prior comparisons
Net income increased 44.4%
Net income changed +44.4% from the comparable as-filed period.
$270.2M→$390.3M2 prior comparisons
Operating margin moved 324 bp higher
Operating margin changed +324 basis points from the comparable as-filed period.
21.37%→24.61%2 prior comparisons
Operating income increased 25.4%
Operating income changed +25.4% from the comparable as-filed period.
$449.6M→$563.7M2 prior comparisons
Short-term borrowings increased 51.1%
Short-term borrowings changed +51.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.3B→$1.9B4 prior comparisons
Capex / revenue moved 2028 bp lower
Capex / revenue changed -2028 basis points from the comparable as-filed period.
74.36%→54.08%0 prior comparisons
Current long-term debt decreased 37.2%
Current long-term debt changed -37.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.3B→$1.4B4 prior comparisons
Capital expenditure increased 52.2%
Capital expenditure changed +52.2% from the comparable as-filed period.
$829.4M→$1.3B3 prior comparisons
Operating cash flow increased 16.3%
Operating cash flow changed +16.3% from the comparable as-filed period.
$853.3M→$992.3M3 prior comparisons
Net income increased 23.9%
Net income changed +23.9% from the comparable as-filed period.
$243.0M→$301.0M2 prior comparisons
Noncurrent long-term debt increased 12.3%
Noncurrent long-term debt changed +12.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$17.1B→$19.2B4 prior comparisons
Capex / revenue moved 1993 bp higher
Capex / revenue changed +1993 basis points from the comparable as-filed period.
41.27%→61.20%0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.